Current routines for transrectal ultrasound-guided prostate biopsy: A web-based survey by the Swedish Urology Network

Scandinavian Journal of Urology and Nephrology

Volumn 46, Issue 6, 2012, Pages 405-410

  Carlsson, Stefan ^a,e   Bratt, Ola ^b   Stattin, Pär ^c,d   Egevad, Lars ^e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Pathology; Prostate cancer; Transrectal ultrasound guided prostate biopsy

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE;

ANTIBIOTIC PROPHYLAXIS; CLINICAL PRACTICE; LOCAL ANESTHESIA; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; SINGLE DRUG DOSE; SWEDEN; TRANSRECTAL ULTRASONOGRAPHY;

ANESTHESIA, LOCAL; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; CIPROFLOXACIN; ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PROSTATIC NEOPLASMS; QUESTIONNAIRES; SPECIMEN HANDLING; SWEDEN; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; UROLOGY;

EID: 84870669406     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.3109/00365599.2012.691111     Document Type: Review

References (21)

1. Åberg A. Socialstyrelsen. Cancer incidence in Sweden 2010. Sveriges officiella statistik. Hälso- och Sjukvård 2011;29.
2. Stattin P, Holmberg E, Johansson JE, Holmberg L, Adolfsson J, Hugosson J. Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow- up study. J Natl Cancer Inst 2010;102: 950-8.
3. Egevad L, Algaba F, Berney DM, Boccon-Gibod L, Griffiths DF, Lopez-Beltran A, et al. The European Network of Uropathology: a novel mechanism for communication between pathologists. Anal Quant Cytol Histol 2009;31: 90-5.
4. Duffield AS, Lee TK, Miyamoto H, Carter HB, Epstein JI. Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails. J Urol 2009;182: 2274-8.
5. Chun FK, Epstein JI, Ficarra V, Freedland SJ, Montironi R, Montorsi F, et al. Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature. Eur Urol 2010;58: 851-64.
6. Ching CB, Moussa AS, Li J, Lane BR, Zippe C, Jones JS. Does transrectal ultrasound probe configuration really matter? End fire versus side fire probe prostate cancer detection rates. J Urol 2009;181: 2077-82; discussion 82-3.
7. Mortimer AM, Ridley N, Cook JL. The influence of ultrasound probe orientation on prostate cancer detection rate during transrectal ultrasonography-guided prostate biopsy. J Endourol 2010;24: 2075-81.
8. Ching CB, Zaytoun O, Moussa AS, Li J, Avallone A, Jones JS. Type of transrectal ultrasonography probe influences prostate cancer detection rates on repeat prostate biopsy. BJU Int 2011 Nov 1; doi: 10.1111/j.1464-410X. 2011.10689.x.
9. Paul R, Korzinek C, Necknig U, Niesel T, Alschibaja M, Leyh H, et al. Influence of transrectal ultrasound probe on prostate cancer detection in transrectal ultrasound-guided sextant biopsy of prostate. Urology 2004;64: 532-6.
10. Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, et al. EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011;59: 61-71.
11. Lee G, Attar K, Laniado M, Karim O. Trans-rectal ultrasound guided biopsy of the prostate: nationwide diversity in practice and training in the United Kingdom. Int Urol Nephrol 2007;39: 185-8.
12. Inal G, Yazici S, Adsan O, Ozturk B, Kosan M, Cetinkaya M. Effect of periprostatic nerve blockade before transrectal ultrasound-guided prostate biopsy on patient comfort: a randomized placebo controlled study. Int J Urol 2004;11: 148-51.
13. Addla SK, Adeyoju AA, Wemyss-Holden GD, Neilson D. Local anaesthetic for transrectal ultrasound-guided prostate biopsy: a prospective, randomized, double blind, placebocontrolled study. Eur Urol 2003;43: 441-3.
14. Zani EL, Clark OA, Rodrigues Netto N Jr. Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev 2011;CD006576.
15. Egevad L, Allsbrook WC Jr, Epstein JI. Current practice of diagnosis and reporting of prostate cancer on needle biopsy among genitourinary pathologists. Hum Pathol 2006;37: 292-7.
16. Franzen S, Giertz G, Zajicek J. Cytological diagnosis of prostatic tumours by transrectal aspiration biopsy: a preliminary report. Br J Urol 1960;32: 193-6.
17. Lane RB Jr, Lane CG, Mangold KA, Johnson MH, Allsbrook WC Jr. Needle biopsies of the prostate: what constitutes adequate histologic sampling? Arch Pathol Lab Med 1998;122: 833-5.
18. Amin M, Boccon-Gibod L, Egevad L, Epstein JI, Humphrey PA, Mikuz G, et al. Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens. Scand J Urol Nephrol Suppl 2005;20-33.
19. Biedrzycki O, Varma M, Berney DM. Variations in the processing of prostatic needle cores in the UK; what is safe? J Clin Pathol 2003;56: 341-3.
20. Vickers AJ, Savage CJ, Shouery M, Eastham JA, Scardino PT, Basch EM. Study of a web-based assessment of functional recovery after radical prostatectomy. Health Qual Life Outcomes 2010;8: 82.
21. Matteson KA, Anderson BL, Pinto SB, Lopes V, Schulkin J, Clark MA. Surveying ourselves: examining the use of a web-based approach for a physician survey. Eval Health Prof 2011;34: 448-63.